Sulphydryl blocker-induced rat colitis is ameliorated by intravenous injection of antibody to colonic surfactant-like particle.

A rat model of experimental colitis and jejunitis induced by iodoacetamide (IA), a sulphydryl blocker is accompanied by increased leukotriene, prostaglandin E2 (PGE2) generation, and nitric oxide synthase (NOS) activity. Rat small intestinal and colonic surfactant-like particles (SLP) that accumulate on the apical surface of mucosal cells have been identified and specific antibodies to them have been produced. The aim of this study was to evaluate a possible role of SLP in IA-induced colitis and jejunitis. Inflammation was induced in Sprague-Dawley rats either by intracolonic administration of 3% IA (0.1 ml) or by intrajejunal administration of 2% IA (0.1 ml). Antisera raised against either colonic SLP, pulmonary SP-A (a major protein associated with colonic SLP), or small intestinal SLP were injected into the tail vein of rats 48 h before, simultaneous with, or 24 h after IA administration. Rats were killed 2 or 10 days after IA was given, their colon or small intestine was isolated and rinsed, and a segment of colon (10 cm) or small bowel (30 cm) was weighed and processed for microscopy, NOS and myeloperoxidase (MPO) activities, and PGE2 generation. Intracolonic or jejunal IA resulted after 48 h in extensive macroscopic and microscopic damage, accompanied by increased segmental weight, MPO and NOS activity, and PGE2 generation. Colonic SLP antibody administration, either 48 h before or at the time of damage induction, significantly decreased macroscopic as well as microscopic damage, segmental weight, MPO activity, and PGE2 generation, but had no effect on NOS activity. Neither control sera nor antisera against SP-A had any protective effect, nor did injection of anti-colonic SLP antisera given 24 h after IA. Small bowel SLP antibody offered no protection against IA jejunitis. IA-induced colitis but not jejunitis is ameliorated by intravenous injection of SLP antibody by a mechanism yet to be determined. These data provide further evidence of a physiologic role for gastrointestinal SLP.

[1]  D. Rachmilewitz,et al.  Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Crohn’s disease , 1997, Gut.

[2]  F. Guarner,et al.  Deranged hydrophobic barrier of the rat gastroduodenal mucosa after parenteral nonsteroidal anti-inflammatory drugs. , 1997, Gastroenterology.

[3]  G. Goetz,et al.  Isolation and characterization of surfactant-like particles in rat and human colon. , 1997, The American journal of physiology.

[4]  F. Guarner,et al.  Incrimination of anaerobic bacteria in the induction of experimental colitis. , 1997, The American journal of physiology.

[5]  R. Hammer,et al.  Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats. , 1996, The Journal of clinical investigation.

[6]  F. Guarner,et al.  Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis. , 1996, Gastroenterology.

[7]  D. Strayer,et al.  Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo. , 1996, American journal of respiratory and critical care medicine.

[8]  L. Lichtenberger,et al.  Molecular association of trinitrobenzenesulfonic acid and surface phospholipids in the development of colitis in rats. , 1996, Gastroenterology.

[9]  R. Eliakim,et al.  A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. , 1995, Gut.

[10]  D. Rachmilewitz,et al.  Sulfhydryl blocker-induced rat colonic inflammation is ameliorated by inhibition of nitric oxide synthase. , 1995, Gastroenterology.

[11]  P. Malfertheiner,et al.  Altered luminal surface hydrophobicity of non-inflammed mucosa in patients with Crohn's disease , 1995 .

[12]  P. Malfertheiner,et al.  Demonstration of a phospholipid-rich zone in the human gastric epithelium damaged by Helicobacter pylori. , 1993, Gastroenterology.

[13]  B. Hills,et al.  Gastric mucosal barrier: evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it. , 1993, Gut.

[14]  D. Alpers,et al.  Characterization of proteins in rat and human intestinal surfactant-like particles. , 1993, Archives of biochemistry and biophysics.

[15]  M. Becich,et al.  Caco-2 cell transfection by rat intestinal alkaline phosphatase cDNA increases surfactant-like particles. , 1992, The American journal of physiology.

[16]  L. Ignarro,et al.  Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. , 1992, Biochemical and biophysical research communications.

[17]  H. Strauss,et al.  Regulation of extracellular calcium entry in endothelial cells: role of intracellular calcium pool. , 1992, The American journal of physiology.

[18]  R. Willén,et al.  Effects of phosphatidylcholine and phosphatidylinositol on acetic-acid-induced colitis in the rat. , 1992, Digestion.

[19]  L. Lichtenberger,et al.  Gastric protective activity of mixtures of saturated polar and neutral lipids in rats. , 1990, Gastroenterology.

[20]  R. Eliakim,et al.  Intestinal surfactant-like material. A novel secretory product of the rat enterocyte. , 1989, The Journal of clinical investigation.

[21]  K. Magnusson.  Physicochemical properties of bacterial surfaces. , 1989, Biochemical Society transactions.

[22]  L. Lichtenberger.  Membranes and barriers: with a focus on the gastric mucosal barrier. , 1987, Clinical and investigative medicine. Medecine clinique et experimentale.

[23]  B. Butler,et al.  Distribution of surfactants in the canine gastrointestinal tract and their ability to lubricate. , 1983, The American journal of physiology.

[24]  M. Siegman,et al.  Chemical energy usage during shortening and work production in mammalian smooth muscle. , 1983, The American journal of physiology.

[25]  D. Priebat,et al.  Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. , 1982, The Journal of investigative dermatology.

[26]  U. Zor,et al.  Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine. , 1978, Gastroenterology.